1. Betaferon: Instructions (Information for Physicians) for Use [in Russian], www.medi.ru .
2. A. N. Boiko, M. Yu. Tatarinova, T. G. Alekseeva, et al., “Monitoring of matrix metalloprotease 9 (MMP) in the assessment of the clinical and biological effects of beta-interferons in relapsing multiple sclerosis,” in: Neuroimmunology. Research, Clinical Feature, Treatment [in Russian], St. Petersburg (2002), pp. 28–30.
3. A. N. Boiko, M. V. Davydovskaya, T. L. Demina, et al., “Experience in the prolonged use of Betaferon and Colpaxone in daily neurological practice – results of a five-year study of multiple sclerosis patients in the Moscow City Multiple Sclerosis Center,” Zh. Nevrol. Psikhiat., Special issue No. 4, Multiple Sclerosis, 84–94 (2007).
4. E. I. Gusev and A. N. Boiko, “Contemporary approaches to the use of beta-interferons in the treatment of multiple sclerosis,” Zh. Nevrol. Psikhiat., 11, 54–59, (2000).
5. E. I. Gusev and A. N. Boiko, Multiple Sclerosis: from Studies of Immunopathogenesis to New Treatment Methods [in Russian], Gubernsksya Meditsina (2001).